Abstract
Viral infections remain a major cause of morbidity and mortality after pediatric hematopoietic stem cell transplantation. Adoptive transfer of donor-derived virus-specific T cells can reconstitute antiviral immunity in recipients and be effective both in preventing and treating cytomegalovirus, Epstein-Barr virus and adenovirus infection. Current efforts are focused on providing protection toward a broader range of viruses safely, rapidly and effectively.
Original language | English (US) |
---|---|
Pages (from-to) | 193-198 |
Number of pages | 6 |
Journal | Bone Marrow Transplantation |
Volume | 41 |
Issue number | 2 |
DOIs | |
State | Published - Jan 2008 |
ASJC Scopus subject areas
- Hematology
- Transplantation